List of Komodo Health Aperture Customers
Komodo Health
680 Folsom St 5th floor,
San Francisco, 94107, CA,
United States
San Francisco, 94107, CA,
United States
1 415-805-1425
Professional Services
700
$110M
Since 2010, our global team of researchers has been studying Komodo Health Aperture customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Komodo Health Aperture for Analytics and BI from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Komodo Health Aperture for Analytics and BI include: Bristol Myers Squibb, a United States based Life Sciences organisation with 34100 employees and revenues of $48.30 billion, GSK, a United Kingdom based Life Sciences organisation with 69310 employees and revenues of $42.21 billion, AstraZeneca US, a United States based Life Sciences organisation with 17535 employees and revenues of $17.74 billion, Cholangiocarcinoma Foundation, a United States based Life Sciences organisation with 20 employees and revenues of $3.0 million, Fight Colorectal Cancer, a United States based Non Profit organisation with 23 employees and revenues of $3.0 million and many others.
Contact us if you need a completed and verified list of companies using Komodo Health Aperture, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Komodo Health Aperture customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AstraZeneca US | Life Sciences | 17535 | $17.7B | United States | Komodo Health | Komodo Health Aperture | Analytics and BI | 2017 | n/a |
In 2017, AstraZeneca US implemented Komodo Health Aperture as an Analytics and BI application. The deployment targeted regional teams and was supported by AstraZeneca US technology staff who provided training on Komodo Health Aperture, Veeva CRM, and Microsoft Suite to operational users.
Komodo Health Aperture was positioned to deliver analytics and BI capabilities for regional operational workflows, with configuration and user enablement managed by the internal tech team. Training activities documented platform navigation, data access patterns, and coordinated cross platform usage with Veeva CRM and Microsoft Suite, and the rollout emphasized governance for user onboarding and ongoing support.
|
 |
Bristol Myers Squibb | Life Sciences | 34100 | $48.3B | United States | Komodo Health | Komodo Health Aperture | Analytics and BI | 2015 | n/a |
In 2015, Bristol Myers Squibb conducted a big data analytics pilot using Komodo Health Aperture 2.0. The pilot deployed Komodo Health Aperture as an Analytics and BI capability to identify new health care provider engagement opportunities for Field Medical and the home office supporting the US Immuno Oncology Franchise Medical team.
Configuration emphasized Aperture 2.0 data ingestion and analytics capabilities to surface HCP engagement opportunities, with functional workflows focused on HCP identification, cohort oriented analysis, and opportunity detection to inform medical engagement planning. The pilot implementation prioritized query driven analytics and user facing dashboards to present actionable signals to franchise medical users.
Access management was implemented via SAML 2.0 to control authentication across field and home office users. Operational coverage explicitly included Field Medical and the home office for the US Immuno Oncology Franchise Medical team, and governance during the pilot centered on data access controls and role aligned permissions to align medical affairs workflows to the Aperture driven opportunity identification process.
|
 |
Cholangiocarcinoma Foundation | Life Sciences | 20 | $3M | United States | Komodo Health | Komodo Health Aperture | Analytics and BI | 2019 | n/a |
In 2019, Cholangiocarcinoma Foundation implemented Komodo Health Aperture to centralize disease burden and research analytics. The deployment positioned Komodo Health Aperture as the foundation's Analytics and BI platform for research and program planning, providing a single environment for population level insight and hypothesis generation.
Komodo Health Aperture was configured to deliver cohort discovery, population level disease burden analysis, epidemiologic analytics, and interactive dashboards tailored to a small research organization. The implementation emphasized data modeling, curated visualizations, and repeatable analytic workflows to support research questions and program prioritization within the foundation.
The platform was operationalized across the foundation's research, program, and advocacy functions with role based access controls and curated analytic workspaces to manage sensitive datasets. The engagement illustrates Komodo Health Aperture being used to help tackle the burden of disease for the Cholangiocarcinoma Foundation and to serve as an Analytics and BI resource for ongoing research activities.
|
 |
Fight Colorectal Cancer | Non Profit | 23 | $3M | United States | Komodo Health | Komodo Health Aperture | Analytics and BI | 2019 | n/a |
In 2019, Fight Colorectal Cancer implemented Komodo Health Aperture to support patient advocacy and research workflows. The deployment used Komodo Health Aperture as an Analytics and BI platform to analyze patterns of care and patient-level datasets, with an explicit focus on identifying providers and regions of the country for targeted intervention.
The implementation emphasized population analytics, longitudinal care pathway analysis, physician referral histories, and patient cohort identification capabilities within Komodo Health Aperture. These capabilities were configured to profile referral networks, map care pathways, and surface gaps in access to biomarker testing, enabling program teams to prioritize outreach and education efforts.
Operational coverage targeted U.S. regions and provider networks most in need of outreach, aligning Komodo Health Aperture outputs with Fight Colorectal Cancer research, advocacy, outreach, and screening coordination activities. The relationship connected analytic outputs to program decisioning, guiding where educational resources and screening promotion should be directed.
Governance centered on cross-functional use between research analysts and outreach teams, instituting data-driven prioritization workflows for provider engagement. The companies seek to increase screening and close gaps in colorectal cancer care, including access to biomarker testing, by using Komodo Health Aperture insights to inform outreach and education strategies.
|
 |
GSK | Life Sciences | 69310 | $42.2B | United Kingdom | Komodo Health | Komodo Health Aperture | Analytics and BI | 2019 | n/a |
In 2019, GSK deployed Komodo Health Aperture within its Analytics and BI tooling to support commercial field reporting and new hire onboarding focused on Zejula data. The implementation placed Komodo Health Aperture as the primary online tool for accessing product level analytics while Tableau remained the visualization and field reporting layer.
The rollout emphasized practical training use cases, with Komodo Health Aperture used to surface Zejula datasets for instructor led and self guided training of new hires. Functional capabilities implemented included analytics exploration, dashboard consumption workflows, and packaged data extracts that were consumed in Tableau for territory and field reporting.
Operational coverage targeted GSK commercial teams and onboarding programs, aligning Aperture deliverables to sales and medical field reporting processes. Governance centered on data access controls, standardized training curricula for Zejula data, and a reporting cadence that integrated Aperture outputs into Tableau distribution workflows.
|
Showing 1 to 5 of 5 entries
Buyer Intent: Companies Evaluating Komodo Health Aperture
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Komodo Health Aperture. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Komodo Health Aperture for Analytics and BI include:
- 5R Design, a United States based Professional Services organization with 10 Employees
- United BioSource, a United States based Life Sciences company with 1500 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated |
|---|---|---|---|---|---|---|
 |
5R Design | Professional Services | 10 | $1M | United States | 2025-11-17 |
 |
United BioSource | Life Sciences | 1500 | $200M | United States | 2025-02-07 |
FAQ - APPS RUN THE WORLD Komodo Health Aperture Coverage
Komodo Health Aperture is a Analytics and BI solution from Komodo Health.
Companies worldwide use Komodo Health Aperture, from small firms to large enterprises across 21+ industries.
Organizations such as Bristol Myers Squibb, GSK, AstraZeneca US, Cholangiocarcinoma Foundation and Fight Colorectal Cancer are recorded users of
Komodo Health Aperture for Analytics and BI.
Companies using Komodo Health Aperture are most concentrated in Life Sciences and Non Profit, with adoption spanning over 21 industries.
Companies using Komodo Health Aperture are most concentrated in United States and United Kingdom, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Komodo Health Aperture across Americas, EMEA, and APAC.
Companies using Komodo Health Aperture range from small businesses with 0-100 employees - 40%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 60%.
Customers of Komodo Health Aperture include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified Komodo Health Aperture customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Analytics and BI.